🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
Asan Medical Center
Start Date
2010-06
Trial ID
NCT01199068
Monotherapy treatment with CS-7017 to assess progression-free-survival (PFS...
Status
Terminated
Location
Fakulti nemocnice Brno
Start Date
2009-07-31
Trial ID
NCT00986440
This phase 2, randomized, active-controlled, open-label, parallel group, mu...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2009-09
Trial ID
NCT00967616
Treatments Being Tested
This phase II trial studies how well inolitazone dihydrochloride (efatutazo...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2014-12-30
Trial ID
NCT02152137
Treatments Being Tested
This is a Phase 2 and open-label (subject will know the treatment he or she...
Status
Completed
Location
DHHA
Start Date
2010-03
Trial ID
NCT01101334
This is a study of CS-7017 designed to allow participants who completed par...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00881569
Treatments Being Tested
An open-label, Phase I, dose escalation study of CS-7017 administered by mo...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00408434
Treatments Being Tested
This phase II trial studies how well efatutazone dihydrochloride works in t...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2015-02-11
Trial ID
NCT02249949
Treatments Being Tested
This study is for patients with advanced solid tumors. The purpose of this ...
Status
Terminated
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2011-12
Trial ID
NCT01504490
Treatments Being Tested
The Phase I/II study will be conducted as an open label, multiple center st...
Status
Terminated
Location
Univ of Colorado Cancer Center
Start Date
2008-01
Trial ID
NCT00603941
Treatments Being Tested